Live Breaking News & Updates on Noel Illien

Stay updated with breaking news from Noel illien. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Roche Joins Race for Obesity Drugs With $2.7 Billion Carmot Deal

Roche agreed to take over unlisted obesity drug developer Carmot Therapeutics for $2.7 billion upfront, joining a list of contestants seeking to challenge the dominant makers of weight-loss drugs Novo Nordisk and Eli Lilly. ....

Stig Hansen , Thomas Schinecker , Sharon Singleton , Roche Graham , Eli Lilly , Teresa Graham , Zuercher Kantonalbank , Ludwig Burger , Lilly Mounjaro , Noel Illien , Novo Nordisk , Carmot Therapeutics , Kimia Therapeutics , Frankfurt Additional , Rachel More , Louise Heavens , Weight Management , Glp 1 Receptor Agonists , Glucagon Like Peptide 1 Receptor Agonists , Weight Loss , Drug Development , Drug Discovery , Drug Pipeline , Drug Development Pipeline ,

Roche joins race for obesity drugs with $2.7bln Carmot deal

Roche joins race for obesity drugs with $2.7bln Carmot deal
zawya.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from zawya.com Daily Mail and Mail on Sunday newspapers.

Thomas Schinecker , Sharon Singleton , Noel Illien , Ludwig Burger , Stig Hansen , Zuercher Kantonalbank , Eli Lilly , Lilly Mounjaro , Novo Nordisk , Carmot Therapeutics , Kimia Therapeutics , Frankfurt Additional , Rachel More , Louise Heavens ,